Daniel Bensen, Chief Discovery Officer at Tyra Biosciences, Inc. (TYRA), sold 8,000 shares at $28.44 ($228K) on 2026-01-12, disclosed to the SEC on 2026-01-20.
Scheduled sale ($228k) by Chief Discovery Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.44 | 6,983 | $199K | 87.0% |
| 2 | $29.08 | 1,017 | $30K | 13.0% |
| Total | $28.52 avg | 8,000 | $228K | 100% |
| Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |
| TYRA | SELL | 2024-06-10 | $74K | — | Filing → |